Published Leukemia cure what could be a breakthrough in the search for a cure against cancer. The word "cancer" simple disguises what is really hundreds of diseases, most caused by genetic mutations that cause cell replication is being out of control. The new study focuses on a deadly form of leukemia, called B-cell acute lymphatic's leukemia, or B- ALL, and described a radically new approach type of cancer using genetic modification of patient's own cells Leukemia cure. First a little history . Leukemia are cancers of the blood , which means that does not form solid tumors at all . Instead , cancer cells circulating in the blood, which is almost everywhere in the body.
The Leukemia cure blood of many types of cells therein, the cells including leukocytes or white blood cells , which is the origin of the word leukemia . Lymphocytes are a type of white blood cell, and the two subtypes are the most commonly called B cells and T cells. B -ALL , then, is a cancer that a B lymphocyte suddenly become cancerous. Scientists have developed to treat chemotherapy B -ALL , but if the first line of Leukemia cure treatment fails and the cancer recurs , the patient faces a bleak prognosis. We do not really effective at this point have treatment , and most patients die . The new treatment of leukemia is a technological achievement . The team at Memorial Sloan- Kettering, and directed by Michel Ernie Bernstein Saddening T cells Leukemia cure genetically modified for each patient , so that these T cells could turn cancerous B cells.
T cells modified using what is called a " chimer antigen receptor " or RCA , which is designed to be attached to a specific protein called CD , which protrudes from the surface of cancerous B cells more . (This technique was invented by another group at Memorial Sloan Leukemia cure -Kettering , led by Isabella Riviera. What is surprising about this study is that in five patients , cancers have virtually disappeared in a few weeks . As described in a report by the New York Times, one of the sickest patients, 58 years , David Appoint , saw his leukemia disappear in just eight days. But we can not know with Leukemia cure certainty whether further therapy alone is a cure. This is because the patients also received stem cell transplants in a few months after the therapy, which may have contributed to eliminate remaining cancer cells.
The therapy itself was very toxic temporary , requiring close monitoring and treatment with steroids to reduce toxic side effects. This is perhaps the reason why a Leukemia cure patient died : corticosteroids may be hampered by the destruction of genetically modified cells. If this treatment is used as first-line treatment of B- ALL, but in patients who have tried conventional therapy and relapse could be even more effective ( as the authors suggest ) . In particular , is likely to be Leukemia cure less toxic to patients who are in early stages of the disease and who have a lower number of tumor cells in the blood . Thus, despite its promise, CAR T cell therapy has to be refined and tested more before declaring a success Leukemia cure.